BCBSM Prior Authorization and Step Therapy Guidelines
... Off-Label / High-Cost Specialty program-Off-label means a drug is being used in a way that has not been approved by the U.S. Food and Drug Administration. Drugs with potential for off-label use and high-cost specialty drugs on this list require prior authorization for Blue Cross to cover them. ...
... Off-Label / High-Cost Specialty program-Off-label means a drug is being used in a way that has not been approved by the U.S. Food and Drug Administration. Drugs with potential for off-label use and high-cost specialty drugs on this list require prior authorization for Blue Cross to cover them. ...
Collagenase clostridium histolyticum
... This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and reta ...
... This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and reta ...
Local anesthetics Part I
... and articaine (Septanest®, Ultracaine®, Septocaine®). Articaine, which has been used in Europe and Canada for a number of years, received FDA approval for use in the United States in April 2000 (6). Procaine (Novocain®), the last ester anesthetic available for clinical use, was removed from the U.S. ...
... and articaine (Septanest®, Ultracaine®, Septocaine®). Articaine, which has been used in Europe and Canada for a number of years, received FDA approval for use in the United States in April 2000 (6). Procaine (Novocain®), the last ester anesthetic available for clinical use, was removed from the U.S. ...
DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC METHOD FOR DETERMINATION
... 30- 150μg/ml with the regression coefficient of 0.999. The method was validated for different parameters as per the ICH (International Conference for Harmonization) guidelines. This method can be used for the determination of Tramadol Hydrochloride in quality control of formulation without interfere ...
... 30- 150μg/ml with the regression coefficient of 0.999. The method was validated for different parameters as per the ICH (International Conference for Harmonization) guidelines. This method can be used for the determination of Tramadol Hydrochloride in quality control of formulation without interfere ...
The Ophthalmology Market
... Limited (although the latter two companies are closely associated). It could it be expected that this is a growing market for epidemiological reasons, but also there is an economic argument for testing to allow effective treatment in the early stages of disease. ...
... Limited (although the latter two companies are closely associated). It could it be expected that this is a growing market for epidemiological reasons, but also there is an economic argument for testing to allow effective treatment in the early stages of disease. ...
Curriculum Guide - WVDE Career Tech
... Have students define each of the terms and concepts from Medication Review (doses and terminology) Drugs often have several names. When a drug is first discovered, it is given a chemical name, which describes the atomic or molecular structure of the drug. The chemical name is thus usually too comple ...
... Have students define each of the terms and concepts from Medication Review (doses and terminology) Drugs often have several names. When a drug is first discovered, it is given a chemical name, which describes the atomic or molecular structure of the drug. The chemical name is thus usually too comple ...
75002402 - lopinavir and ritonavir tabs - outsert
... In clinical trials of modafinil, the incidence of rash resulting in discontinuation was approximately 0.8% (13 per 1,585) in pediatric patients (age < 17 years); these rashes included one case of possible Stevens-Johnson Syndrome (SJS) and one case of apparent multi-organ hypersensitivity reaction. ...
... In clinical trials of modafinil, the incidence of rash resulting in discontinuation was approximately 0.8% (13 per 1,585) in pediatric patients (age < 17 years); these rashes included one case of possible Stevens-Johnson Syndrome (SJS) and one case of apparent multi-organ hypersensitivity reaction. ...
Psychometric assessment of the Hallucinogen Rating Scale Drug Alcohol Depend 137
... in their habitual setting. In Study 2 (delayed assessment), 56 adult polydrug users answered the HRS and a short form of the Addiction Research Center Inventory (ARCI) recalling the effects they experienced when they last took a hallucinogen, in order to test the convergent-discriminant validity of ...
... in their habitual setting. In Study 2 (delayed assessment), 56 adult polydrug users answered the HRS and a short form of the Addiction Research Center Inventory (ARCI) recalling the effects they experienced when they last took a hallucinogen, in order to test the convergent-discriminant validity of ...
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE
... Chloride can lower the levels of methaemoglobin in the red blood cells. It activates a normally dormant reductase enzyme system which reduces the Methylthioninium Chloride to leucomethylthioninium chloride, which in turn is able to reduce methaemoglobin to haemoglobin. However, in large doses, Methy ...
... Chloride can lower the levels of methaemoglobin in the red blood cells. It activates a normally dormant reductase enzyme system which reduces the Methylthioninium Chloride to leucomethylthioninium chloride, which in turn is able to reduce methaemoglobin to haemoglobin. However, in large doses, Methy ...
Covariate Analysis of QTc and T
... This study adds the dimension of a T-wave morphology composite score (MCS) to the QTc interval–based evaluation of drugs that affect cardiac repolarization. Electrocardiographic recordings from 62 subjects on placebo and 400 mg moxifloxacin were compared with those from 21 subjects on 160 and 320 mg ...
... This study adds the dimension of a T-wave morphology composite score (MCS) to the QTc interval–based evaluation of drugs that affect cardiac repolarization. Electrocardiographic recordings from 62 subjects on placebo and 400 mg moxifloxacin were compared with those from 21 subjects on 160 and 320 mg ...
Devil`s claw
... Good tolerance-safety. No negative effect on cognition or motor coordination. No addiction. No rebound. ...
... Good tolerance-safety. No negative effect on cognition or motor coordination. No addiction. No rebound. ...
support and other appropriate agents and is indicated for the
... the study was to determine whether INOmax would reduce the receipt of ECMO in these patients. Hypoxic respiratory failure was caused by MAS (35%), idiopathic PPHN (30%), pneumonia/sepsis (24%), or RDS (8%). Patients with a mean PaO2 of 54 mm Hg and a mean OI of 44 cm H2O / mm Hg were randomly assign ...
... the study was to determine whether INOmax would reduce the receipt of ECMO in these patients. Hypoxic respiratory failure was caused by MAS (35%), idiopathic PPHN (30%), pneumonia/sepsis (24%), or RDS (8%). Patients with a mean PaO2 of 54 mm Hg and a mean OI of 44 cm H2O / mm Hg were randomly assign ...
ERY-PED - Arbor Pharmaceuticals
... treatment with other agents. Acute Pelvic Inflammatory Disease Caused by Neisseria gonorrhoeae: As an alternative drug in treatment of acute pelvic inflammatory disease caused by N. gonorrhoeae in female patients with a history of sensitivity to penicillin. Patients should have a serologic test ...
... treatment with other agents. Acute Pelvic Inflammatory Disease Caused by Neisseria gonorrhoeae: As an alternative drug in treatment of acute pelvic inflammatory disease caused by N. gonorrhoeae in female patients with a history of sensitivity to penicillin. Patients should have a serologic test ...
Therapeutic Focus - Abeille Pharmaceuticals, Inc
... are shown in Table 2. It is apparent that a transdermal anti-emetic product comes closest to satisfying the profile of an ideal antiemetic product. Abeille Pharmaceuticals, Inc., has a transdermal anti-emetic product at an advanced stage of development. Some of the advantages of a transdermal produc ...
... are shown in Table 2. It is apparent that a transdermal anti-emetic product comes closest to satisfying the profile of an ideal antiemetic product. Abeille Pharmaceuticals, Inc., has a transdermal anti-emetic product at an advanced stage of development. Some of the advantages of a transdermal produc ...
Selected Operating and Administrative Practices of the Bureau of
... also showed that thousands of prescriptions that were supposedly destroyed may have actually been used. In some cases, these documents may have gone missing from the form supplier’s facilities, or even the Bureau’s own offices, due to lack of controls and proper records. As a result of the audit, th ...
... also showed that thousands of prescriptions that were supposedly destroyed may have actually been used. In some cases, these documents may have gone missing from the form supplier’s facilities, or even the Bureau’s own offices, due to lack of controls and proper records. As a result of the audit, th ...
Corticosteroids in the treatment of dengue shock syndrome
... series of 22 children with dengue shock syndrome, nine out of eleven patients treated with methylprednisolone survived, while all patients not given steroids died.40 Nonetheless, many subsequent controlled studies of corticosteroids in dengue shock syndrome failed to show benefit,41–45 and a Cochran ...
... series of 22 children with dengue shock syndrome, nine out of eleven patients treated with methylprednisolone survived, while all patients not given steroids died.40 Nonetheless, many subsequent controlled studies of corticosteroids in dengue shock syndrome failed to show benefit,41–45 and a Cochran ...
Journal of Cannabis Therapeutics, Vol. 1 - cannabis
... Methods. Technical reports were obtained from 6 states which had conducted clinical trials. Each protocol was examined for the procedure used, the experimental design of the clinical trial and the results obtained. Data were available on 748 patients who smoked marijuana prior to and/or after cancer ...
... Methods. Technical reports were obtained from 6 states which had conducted clinical trials. Each protocol was examined for the procedure used, the experimental design of the clinical trial and the results obtained. Data were available on 748 patients who smoked marijuana prior to and/or after cancer ...
APPLICATION CHECKLIST (ICH CTD)
... APPENDIX 3A APPLICATION CHECKLIST (ASEAN CTD – NDA and GDA) This Application Checklist should be used to ensure submission of a complete dataset in the ASEAN Common Technical Dossier (ACTD) format for NDA and GDA applications only. All documents required under Part I must be submitted in softcopy in ...
... APPENDIX 3A APPLICATION CHECKLIST (ASEAN CTD – NDA and GDA) This Application Checklist should be used to ensure submission of a complete dataset in the ASEAN Common Technical Dossier (ACTD) format for NDA and GDA applications only. All documents required under Part I must be submitted in softcopy in ...
PALS drugs
... children is dynamic. Advances in management options and drug therapies occur rapidly. Readers are advised to check for changes in recommended doses, indications, and contraindications in the following sources: Currents in Emergency Cardiovascular Care, which is available at http://www.americanheart. ...
... children is dynamic. Advances in management options and drug therapies occur rapidly. Readers are advised to check for changes in recommended doses, indications, and contraindications in the following sources: Currents in Emergency Cardiovascular Care, which is available at http://www.americanheart. ...
Apotex Launches First Generic Plavix®
... Apotex Launches First Generic Plavix® Consumers Have Immediate Access to an Affordable Version of this Important Product Weston, Fl (August 8, 2006) - Apotex Corp. announced that it has today launched clopidogrel bisulfate 75 mg tablets. Clopidogrel is the generic equivalent of Sanofi's Plavix®, whi ...
... Apotex Launches First Generic Plavix® Consumers Have Immediate Access to an Affordable Version of this Important Product Weston, Fl (August 8, 2006) - Apotex Corp. announced that it has today launched clopidogrel bisulfate 75 mg tablets. Clopidogrel is the generic equivalent of Sanofi's Plavix®, whi ...
Paracetamol versus placebo or physical methods for treating fever in
... Two reviewers independently extracted data on methods, types of participants, interventions, and outcomes. The meta-analysis was conducted using risk ratio with 95% confidence intervals for discrete variables, and mean differences for continuous outcomes. Main results 12 trials (n = 1509 participant ...
... Two reviewers independently extracted data on methods, types of participants, interventions, and outcomes. The meta-analysis was conducted using risk ratio with 95% confidence intervals for discrete variables, and mean differences for continuous outcomes. Main results 12 trials (n = 1509 participant ...
R Re ed du
... might have suggested an increase in airway inflammation, or a rebound effect of β2-agonist withdrawal. We did not observe any overall improvement in asthma control. It is possible, however, that a longer treatment period is needed before any clinical improvement might result. In the study by SEARS e ...
... might have suggested an increase in airway inflammation, or a rebound effect of β2-agonist withdrawal. We did not observe any overall improvement in asthma control. It is possible, however, that a longer treatment period is needed before any clinical improvement might result. In the study by SEARS e ...
274 Antibacterials
... occurred after the second month of treatment. In the 928 patients who only received 2 months of ethambutol therapy, ocular toxicity was not reported. A prospective study3 of 229 patients taking ethambutol for Mycobacterium avium complex lung disease reported that ocular toxicity was more common in p ...
... occurred after the second month of treatment. In the 928 patients who only received 2 months of ethambutol therapy, ocular toxicity was not reported. A prospective study3 of 229 patients taking ethambutol for Mycobacterium avium complex lung disease reported that ocular toxicity was more common in p ...
product monograph including patient
... Nitroglycerin overdose may result in severe hypotension, persistent throbbing headache, vertigo, palpitations, visual disturbances, flushing, and perspiring skin (later becoming cold and cyanotic), nausea and vomiting (possibly with colic and even bloody diarrhea), syncope (especially in the upright ...
... Nitroglycerin overdose may result in severe hypotension, persistent throbbing headache, vertigo, palpitations, visual disturbances, flushing, and perspiring skin (later becoming cold and cyanotic), nausea and vomiting (possibly with colic and even bloody diarrhea), syncope (especially in the upright ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.